[Renal dysfunction and anemia in old patients with diastolic cardiac failure]

Terapevticheskii Arkhiv
|January 29, 2008
PubMed

Insights

Anemia and reduced kidney function in elderly patients with chronic diastolic cardiac failure (CDCF) worsen symptoms and impact left ventricular diastolic filling. Lower glomerular filtration rate (GFR) prolongs relaxation, while lower hemoglobin increases early filling velocity.

Area of Science:

  • Cardiology
  • Nephrology
  • Geriatrics

Context:

  • Chronic diastolic cardiac failure (CDCF) affects elderly individuals.
  • Renal insufficiency and anemia are common comorbidities in this population.
  • Diastolic dysfunction significantly impacts cardiac function and patient outcomes.

Purpose:

  • To investigate the influence of renal functional insufficiency and anemia on clinical presentation and left ventricular diastolic filling in elderly patients with CDCF.
  • To determine the relationship between glomerular filtration rate (GFR), hemoglobin levels, and diastolic function parameters.

Summary:

  • The study examined 116 elderly patients with CDCF, assessing renal function (GFR) and anemia.
  • A significant percentage of patients had reduced GFR (36.2%) and anemia (28.4%), with a notable overlap (18.1%).
  • Results indicated a direct correlation between hemoglobin and GFR, and that reduced GFR prolonged isovolumic relaxation time, while lower hemoglobin increased early diastolic filling velocity.

Impact:

  • Findings highlight the critical role of renal function and anemia in modulating diastolic function in elderly CDCF patients.
  • This underscores the importance of managing these comorbidities to improve clinical outcomes.
  • The study provides insights into the complex interplay of factors affecting diastolic filling in this vulnerable group.
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...